Abstract
BackgroundUse of anti-TNF biologic agents in rheumatoid arthritis has been linked to an increased risk of infections. Both administrative and clinical datasets have limitations with case identification which may affect...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
